Kestra Advisory Services’s Virtus Biotech ETF BBP Stock Holding History

Kestra Advisory Services’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$400K	Buy	+4,160	New	+$362K	﹤0.01%	2517

Other funds holding BBP

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Kestra Advisory Services's BBP Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in Virtus Biotech ETF (BBP) in Q2 2026: 4,160 shares worth $400K. The stake represents ﹤0.01% of the portfolio and ranks #2517 among its holdings.

8 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

Kestra Advisory Services held 4,160 shares of Virtus Biotech ETF worth $400K as of Q2 2026.
Virtus Biotech ETF was a new Kestra Advisory Services position in Q2 2026.
Virtus Biotech ETF made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2517 holding.
8 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.